New psoriasis pill shows promise in major trial
NCT ID NCT07362017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called ponesimod in 300 adults with moderate-to-severe plaque psoriasis. The goal is to see if it is safe and helps control the disease. Participants take the drug and are monitored for side effects and skin improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanda Investigational Site
RECRUITINGGlendale, Arizona, 85308, United States
-
Vanda Investigational Site
RECRUITINGFremont, California, 94538, United States
-
Vanda Investigational Site
RECRUITINGRochester, New York, 14623, United States
-
Vanda Investigational Site
RECRUITINGSpokane, Washington, 99202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for kids with severe psoriasis: drug trial shows promise
- New psoriasis drug shows promise in chinese trial
- New psoriasis drug shows promise in major trial
- New psoriasis drug bimekizumab outperforms secukinumab in major trial
- New psoriasis drug shows promise in large trial
- New hope for kids with psoriasis: cosentyx® shows promise in chinese study